Assignee
PAJVANI UTPAL
US·2 granted patents·5 pending applications·0 citations·filing 2015–2020
Top patents by PatentIndex Score
7 records- 0146US2018303901A1Notch1 Decoy Antagonists Protect From Obesity-Induced Insulin Resistance and Fatty LiverPAJVANI UTPAL·Filed 2018·Application pending·0 cites
- 0243US10801068B2JAG1 expression predicts therapeutic response in NASHPAJVANI UTPAL·Filed 2016·Granted Oct 13, 2020·0 cites·14 claims
- 0343US2021025003A1Jag1 expression predicts therapeutic response in nashPAJVANI UTPAL·Filed 2020·Application pending·0 cites
- 0440US10149855B2Gamma-secretase inhibition reduce APOC3 levels and plasma triglyceridesPAJVANI UTPAL·Filed 2015·Granted Dec 11, 2018·0 cites·19 claims
- 0540US2017014477A1Free raptor reduces aging- and obesity-induced fatty liverPAJVANI UTPAL·Filed 2016·Application pending·0 cites
- 0639US2019091234A1Gamma-secretase inhibition reduce apoc3 levels and plasma triglyceridesPAJVANI UTPAL·Filed 2018·Application pending·0 cites
- 0738US2016030513A1Notch1 Decoy Antagonists Protect From Obesity-Induced Insulin Resistance and Fatty LiverPAJVANI UTPAL·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →